Q3 2022 Bioatla Inc Earnings Call Transcript

Nov 03, 2022 / 08:30PM GMT
Operator

Good day and welcome to the BioAlta (sic - BioAtla) third-quarter 2022 earnings conference call; pardon me: BioAtla. (Operator instructions) Please note this event is being recorded. I would now like to turn the conference over to Bruce Mackle from LifeSci Advisors. Please, go ahead.

Bruce Mackle - LifeSci Advisors, LLC - IR

Thank you, operator, and good afternoon, everyone. With me today on the phone from BioAtla are Dr. Jay Short, Chairman, CEO, and Co-Founder; Scott Smith, President; Philippe Martin, Chief of Clinical Development and Operations; Sherry Lydick, Senior Vice President, Commercial Strategy; and Richard Waldron, Chief Financial Officer. Earlier this afternoon, BioAtla released financial results and a business update for the quarter ended September 30, 2022. A copy of the press release is available on the company's website.

Before we begin, I'd like to remind everyone that statements made during this conference call will include forward-looking statements, including, but not limited to, statements regarding BioAtla's business plans and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot